Envista Holdings Corp. (NVST)

Over the past six months, Envista Holdings Corp. stock has experienced notable events, increasing by 42.39% between March 24, 2025, and March 20, 2026. The stock's price has increased by 43.33% over the last 12 months, with a year-to-date return of 11.94% as of March 30, 2026. Key events include strong Q3 CY2025 earnings with sales of $670 million and core sales growth of 9.4% year-on-year, as well as better-than-expected revenue and non-GAAP profit for Q4 CY2025 with sales up 15% year-on-year to $750.6 million. Despite positive earnings reports, the stock has shown some recent volatility, decreasing by 16.78% in the past month leading up to March 30, 2026.

While specific detailed information on the demand seasonality for Envista Holdings Corp.'s products and services is not explicitly provided, one source mentions that investment needs can be seasonal, causing short-term swings in free cash flow. This suggests that certain operational or capital expenditures might fluctuate throughout the year, which could indirectly relate to demand cycles or production schedules.

Envista Holdings Corp. is a global dental products company that develops, manufactures, and markets dental consumables, equipment, and services. It operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry, also categorized as Dental Equipment & Technology. Envista unites over 30 trusted brands, including Nobel Biocare, Ormco, DEXIS, and Kerr. The company's business is divided into Specialty Products & Technologies, focusing on implant-based tooth replacements and orthodontic solutions, and Equipment & Consumables, providing dental equipment and supplies used in dental offices.

Envista Holdings Corp. has a global presence, operating in over 120 countries. Approximately 52% of its sales are generated from North America, with emerging markets accounting for 21% of revenue. The company also generates significant revenue from Western Europe and other developed markets.

Envista Holdings Corp. maintains a strong brand reputation, built upon a legacy of innovation and expertise in the dental industry. The company unites more than 30 trusted dental brands. Successful product launches, such as DTX Studio Clinic with AI and the Spark product line, along with strong financial performance in Q3 and Q4 2025, contribute to a positive perception. Envista emphasizes partnering with professionals to improve lives and supports dental professionals at every patient interaction.

Envista Holdings Corp. has a significant institutional ownership base, with 434 institutional owners and shareholders holding 193,675,861 shares, accounting for approximately 96.26% of the company's shares. Major institutional owners include BlackRock, Inc., Vanguard Group Inc, and Ariel Investments, Llc. The largest individual shareholder is Lihui Song, owning 30.88 million shares, representing 18.84% of the company.